Alkermes ALKS Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's additional paid-in capital?
- Alkermes (ALKS) reported additional paid-in capital of $3.06B in Q1 2026.
- How has Alkermes's additional paid-in capital changed year-over-year?
- Alkermes's additional paid-in capital increased by 4.9% year-over-year, from $2.91B to $3.06B.
- What is the long-term trend for Alkermes's additional paid-in capital?
- Over 5 years (2020 to 2025), Alkermes's additional paid-in capital has grown at a 2.3% compound annual growth rate (CAGR), from $2.69B to $3B.
- What does additional paid-in capital mean?
- Capital contributed by shareholders above the nominal par value of the stock.
- How do you interpret additional paid-in capital?
- Increases reflect successful equity financing rounds or the exercise of employee stock options.
- How does additional paid-in capital compare across companies?
- High in growth-stage biotech companies due to frequent equity financing to fund R&D.